Charles Cherington, Director, 10% Owner at Brooklyn ImmunoTherapeutics, Inc. (BTX), sold 400,000 shares at $15.74 ($6.3M) on 2021-06-17, disclosed to the SEC on 2021-06-21.
Open-market sale of $6.3M BTX by Director, 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $15.73 | 200,000 | $3.1M | 50.0% |
| 2 | $15.74 | 198,000 | $3.1M | 49.5% |
| 3 | $16.30 | 2,000 | $33K | 0.5% |
| Total | $15.74 avg | 400,000 | $6.3M | 100% |
| Filing → |
| ERNA | BUY | 2025-04-04 | $754K | — | Filing → |
| CMRA | BUY | 2023-09-11 | $2.1M | — | Filing → |
| CMRA | BUY | 2023-08-25 | $898K | — | Filing → |